Rubicon Research
add_icon

Rubicon Research

1,724.70
-35.90
(-2.04%)
Market Cap
28,523.56 Cr
PE Ratio
101.22
Volume
2,74,829.00
Day High - Low
1,776.00 - 1,701.00
52W High-Low
1,820.10 - 570.75
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
28,523.56 Cr
EPS
15.52
PE Ratio
101.22
PB Ratio
22.63
Book Value
77.86
EBITDA
408.00
Dividend Yield
0.08 %
Industry
Healthcare
Return on Equity
19.14
Debt to Equity
0.40
Analyst Rating and Forecast
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Rubicon Research Limited has filed its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with BSE and NSE.
positive
Rubicon Research Q1 profit surges 96% YoY9 days ago
Rubicon Research reported a 96% year-on-year jump in net profit to ₹848 million for Q1, driven by an 51% revenue increase to ₹5.3 billion and margin expansion.
positive
Rubicon Research schedules 27th AGM for Aug 26, 2026. Key agenda items include a ₹1.50 dividend proposal, KIA Health Tech merger, and new ESOP plan approval.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,902.40
#1 4,56,449.48
37.64
#1 61,673.90
12.69
#1 11,565
26.53
43.08
8,597.00
2,28,223.34
77.94
11,067.00
13.95
2,568
65.50
73.35
4,896.50
1,86,247.12
88.12
13,886.20
20.34
2,138
3.28
48.73
1,432.20
1,15,699.61
34.61
29,044.60
2.24
3,870
-39.18
45.95
1,120.00
1,12,698.21
24.08
27,657.90
17.64
5,026
-34.90
48.15
2,201.80
1,00,673.46
#1 18.15
29,038.90
#1 26.75
5,356
16.00
29.34
2,384.00
98,458.24
47.64
14,636.40
14.85
1,938
29.13
39.76
1,174.70
98,048.58
30.97
35,058.60
3.90
4,158
-69.10
43.08
1,802.00
97,282.16
90.34
6,867.80
22.01
890
#1 123.93
60.02
1,621.30
93,286.02
25.14
34,145.20
5.56
3,503
25.21
54.01
Growth Rate
Revenue Growth
36.79 %
Net Income Growth
83.56 %
Cash Flow Change
28.82 %
ROE
-22.95 %
ROCE
-30.01 %
EBITDA Margin (Avg.)
11.35 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
317
299
314
358
353
413
479
517
540
Expenses
257
234
244
286
273
318
367
395
405
EBITDA
61
64
70
73
80
95
112
121
135
Operating Profit %
19 %
21 %
22 %
20 %
22 %
23 %
23 %
23 %
24 %
Depreciation
9
8
9
10
10
12
12
12
15
Interest
10
7
8
12
11
11
10
10
9
Profit Before Tax
41
49
53
51
60
72
91
99
110
Tax
16
15
15
15
16
18
18
22
26
Net Profit
26
35
38
36
43
54
73
77
85
EPS in ₹
1.66
2.27
2.50
2.37
2.81
3.49
4.46
4.68
5.13

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
2026
Total Assets
430
538
560
750
1,110
1,451
2,327
Fixed Assets
157
188
193
199
307
327
532
Current Assets
265
340
328
502
763
1,063
1,682
Capital Work in Progress
2
6
3
25
10
7
41
Investments
19
14
0
0
0
0
27
Other Assets
252
331
364
526
793
1,118
1,728
Total Equity & Liabilities
430
538
560
750
1,110
1,451
2,327
Current Liabilities
78
111
184
361
573
786
836
Non Current Liabilities
12
53
71
102
152
124
202
Total Equity
341
374
305
286
385
541
1,289
Reserve & Surplus
335
369
300
281
370
526
1,272
Share Capital
5
5
5
5
15
15
17

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
1
67
-46
16
-4
54
81
Investing Activities
-84
-46
-46
-32
-68
-65
-407
Operating Activities
6
62
-63
-75
21
159
205
Financing Activities
80
52
63
123
44
-40
283

Share Holding

% Holding
Jul 2024
Sept 2025
Oct 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
84.15 %
59.99 %
59.99 %
59.99 %
59.86 %
59.76 %
FIIs
0.00 %
9.37 %
9.37 %
7.99 %
7.54 %
7.52 %
DIIs
0.00 %
10.54 %
10.54 %
9.45 %
10.02 %
9.43 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
18.28 %
18.28 %
2.71 %
2.82 %
3.46 %
Others
15.85 %
1.82 %
1.82 %
19.86 %
19.76 %
19.84 %
No of Share Holders
15
1,05,311
1,05,311
31,914
33,738
43,254

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 1.5
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.09

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
26 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Aug 2026 1,440.20 1,724.70
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 638.50 627.25
03 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
03 Feb 2026 650.05 688.90
29 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2026 969.10 967.90
07 Aug 2026 DIVIDEND Dividend
₹ 1.50 /share
07 Aug 2026 967.90 1,533.05
14 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Aug 2026 1,533.05 1,620.70

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript4 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication8 days ago
Audio Recording Of Earnings Conference Call For The Quarter Ended 30Th June 2026.9 days ago
Announcement under Regulation 30 (LODR)-Monitoring Agency Report9 days ago
Announcement under Regulation 30 (LODR)-Change in Management9 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation9 days ago
Board Meeting Outcome for Unaudited Financials Results For Quarter Ended June 30 20269 days ago
Reg. 34 (1) Annual Report.10 days ago
Reg. 34 (1) Annual Report.Aug 11, 2026
Earnings Conference CallAug 07, 2026
Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2026Aug 07, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 04, 2026
Business Responsibility and Sustainability Reporting (BRSR)Aug 03, 2026
Notice Of 27Th Annual General Meeting Along With Integrated Annual Report Of The Company For The Financial Year 2025-26 And Letter For Weblink To Access Notice And The Integrated Annual ReportAug 03, 2026
Newspaper Advertisement Titled Information Regarding 27Th Annual General Meeting To Be Held Through Video Conferencing/ Other Audio-Visual Means Final Dividend And Record Date InformationJul 30, 2026
Communication On Tax Deduction At Source On DividendJul 29, 2026
Filing Of Scheme Of Merger Of Kia Health Tech Private Limited (Wholly Owned Subsidiary) With Rubicon Research Limited - For Disclosure Purposes Only In Terms Of The Exemption Under Paragraph 4 Of SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 DaJul 22, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 22, 2026
Record Date For Payment Of Final Dividend - Friday August 7 2026Jul 20, 2026
Outcome Of Board MeetingJul 20, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 20, 2026
Certificate Under Regulation 74(5) Of SEBI (Depositories And Participants) Regulations 2018 For The Quarter Ended June 30 2026.Jul 09, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - US FDA Inspection Of The CompanyS Manufacturing Facility In Pithampur Madhya PradeshJul 03, 2026
Closure of Trading WindowJun 29, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 02, 2026
Earnings Call Audio RecordingMay 30, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 29, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2026
Statement On Deviation/Variation Of Funds And Further Extension Of Timeline For Utilization Of IPO Proceeds.May 29, 2026
Corporate Action-Board approves DividendMay 29, 2026
Formulation And Adoption Of New Employee Benefit PlanMay 29, 2026
Audited Financial Results For The Quarter And Year Ended 31 March 2026 And Recommendation Of DividendMay 29, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 29, 2026
Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended March 31 2026 And Recommendation Of DividendMay 29, 2026
Earnings Conference CallMay 25, 2026
Board Meeting Intimation for Intimation Of Board MeetingMay 22, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) - Completion Of Acquisition Of Securities In Arinna Lifesciences LimitedApr 30, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 27, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Outcome Of USFDA Inspection At The CompanyS R&D Facility In CanadaApr 24, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Outcome Of USFDA Inspection At The CompanyS R&D Facility In CanadaApr 24, 2026
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Apr 22, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 15, 2026
Announcement under Regulation 30 (LODR)-AcquisitionApr 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 13, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 31, 2026
Closure of Trading WindowMar 31, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 16, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 16, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bajaj Finserv Small Cap Fund Direct-Growth
4.09%
-11070
-0.09%
0.74%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.02%
-2
0.00%
0.02%
JioBlackRock Flexi Cap Fund Direct-Growth
0.18%
0
0.01%
0.05%
Bajaj Finserv Healthcare Fund Direct-Growth
6.01%
0
0.00%
-0.01%
Bajaj Finserv Multi Asset Allocation Fund Direct-Growth
1.40%
0
0.00%
-0.02%
Bajaj Finserv Flexi Cap Fund Direct-Growth
1.83%
0
0.00%
-0.06%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.29%
0
0.00%
0.01%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Canara Robeco Manufacturing Fund Direct-Growth
2.82%
0
0.00%
0.17%
Edelweiss Recently Listed IPO Fund Direct-Growth
2.84%
0
0.00%
0.24%
Groww Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
HDFC Business Cycle Fund Direct-Growth
0.00%
0
0.00%
0.00%
HDFC Innovation Fund Direct-Growth
2.47%
0
-0.03%
0.62%
HDFC Pharma And Healthcare Fund Direct-Growth
1.61%
0
0.00%
-0.09%
ICICI Prudential Exports and Services Fund Direct-Growth
1.21%
0
0.00%
0.00%
ICICI Prudential Long Term Wealth Enhancement Fund Direct-Growth
0.51%
0
0.01%
0.51%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth
0.00%
0
0.00%
0.00%
ICICI Prudential Smallcap Fund Direct Plan-Growth
0.08%
0
0.00%
0.08%
Kotak Healthcare Fund Direct-Growth
2.18%
0
0.00%
0.11%
Angel One Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
PGIM India Flexi Cap Fund Direct-Growth
0.54%
0
0.00%
0.03%
Kotak Midcap Fund Direct-Growth
0.81%
0
0.00%
0.03%
Mirae Asset Healthcare Fund Direct-Growth
0.00%
0
0.00%
0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Bajaj Finserv Balanced Advantage Fund Direct-Growth
1.62%
0
0.00%
-0.01%

Technical Indicators

RSI(14)
Neutral
64.22
ATR(14)
Volatile
73.43
STOCH(9,6)
Overbought
81.87
STOCH RSI(14)
Neutral
61.85
MACD(12,26)
Bullish
10.36
ADX(14)
Strong Trend
32.68
UO(9)
Bearish
60.85
ROC(12)
Uptrend And Accelerating
9.53
WillR(14)
Neutral
-26.61